JPWO2020117564A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020117564A5
JPWO2020117564A5 JP2021531637A JP2021531637A JPWO2020117564A5 JP WO2020117564 A5 JPWO2020117564 A5 JP WO2020117564A5 JP 2021531637 A JP2021531637 A JP 2021531637A JP 2021531637 A JP2021531637 A JP 2021531637A JP WO2020117564 A5 JPWO2020117564 A5 JP WO2020117564A5
Authority
JP
Japan
Prior art keywords
site
skin
drug
microneedle
microneedles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021531637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022510007A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063351 external-priority patent/WO2020117564A1/en
Publication of JP2022510007A publication Critical patent/JP2022510007A/ja
Publication of JPWO2020117564A5 publication Critical patent/JPWO2020117564A5/ja
Priority to JP2024153896A priority Critical patent/JP2024170568A/ja
Pending legal-status Critical Current

Links

JP2021531637A 2018-12-03 2019-11-26 大型薬物の送達改善 Pending JP2022510007A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024153896A JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862774677P 2018-12-03 2018-12-03
US62/774,677 2018-12-03
US201962789407P 2019-01-07 2019-01-07
US62/789,407 2019-01-07
US201962808274P 2019-02-20 2019-02-20
US62/808,274 2019-02-20
PCT/US2019/063351 WO2020117564A1 (en) 2018-12-03 2019-11-26 Improved delivery of large agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024153896A Division JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Publications (2)

Publication Number Publication Date
JP2022510007A JP2022510007A (ja) 2022-01-25
JPWO2020117564A5 true JPWO2020117564A5 (enExample) 2022-12-05

Family

ID=68966029

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531637A Pending JP2022510007A (ja) 2018-12-03 2019-11-26 大型薬物の送達改善
JP2024153896A Pending JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024153896A Pending JP2024170568A (ja) 2018-12-03 2024-09-06 大型薬物の送達改善

Country Status (12)

Country Link
US (1) US20220031595A1 (enExample)
EP (1) EP3890704A1 (enExample)
JP (2) JP2022510007A (enExample)
KR (1) KR20210102301A (enExample)
CN (2) CN113423381A (enExample)
AU (2) AU2019391791A1 (enExample)
BR (2) BR122023023068A2 (enExample)
CA (1) CA3119043A1 (enExample)
IL (1) IL283627A (enExample)
MX (2) MX2021006102A (enExample)
SG (1) SG11202104838SA (enExample)
WO (1) WO2020117564A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
WO2023287726A1 (en) 2021-07-12 2023-01-19 Penland Foundation Treatment of cancer using botulinum toxin and nitrous oxide
KR20230024669A (ko) * 2021-08-12 2023-02-21 주식회사 페로카 마이크로니들 패치
CN114191376B (zh) * 2022-01-05 2024-03-01 中国药科大学 一种用于治疗阿尔兹海默症的微针贴片及其制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US296006A (en) 1884-04-01 John hoefleb
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US6939852B2 (en) 1991-09-24 2005-09-06 Allergan, Inc. Methods and compositions for the treatment of cerebral palsy
US7384918B2 (en) 1991-09-24 2008-06-10 Allergan, Inc. Botulinum toxin for treating muscle contracture
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5512547A (en) 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5965154A (en) 1998-03-17 1999-10-12 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
SG160358A1 (en) 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of an oligopeptide
US20100228225A1 (en) 2006-02-17 2010-09-09 David Cipolla Method and system for delivery of neurotoxins
EP2015773A4 (en) 2006-04-27 2010-05-05 Anterios Inc EXAMINATION OF THE EFFECTS OF TOPICAL ADMINISTRATION OF CHEMICALLY DENOMINATING PHARMACEUTICALS
US20120150023A1 (en) 2007-08-06 2012-06-14 Kaspar Roger L Microneedle arrays for active agent delivery
MX2010013562A (es) * 2008-06-26 2011-02-15 Anterios Inc Aplicacion dermica.
WO2010056922A2 (en) * 2008-11-12 2010-05-20 Kythera Biopharmaceuticals, Inc. Systems and methods for delivery of biologically active agents
RU2494769C2 (ru) * 2008-11-18 2013-10-10 3М Инновейтив Пропертиз Компани Массив полых микроигл и способ его использования
SG10201405582YA (en) 2008-12-31 2014-10-30 Revance Therapeutics Inc Injectable Botulinum Toxin Formulations
HUE051711T2 (hu) * 2010-06-01 2021-03-29 Seqirus Uk Ltd Influenzavakcina antigénjeinek koncentrálása liofilizálás nélkül
WO2012103035A1 (en) 2011-01-24 2012-08-02 Anterios, Inc. Nanoparticle compositions
SG10201804552WA (en) 2011-01-24 2018-07-30 Anterios Inc Nanoparticle compositions, formulations thereof, and uses therefor
EP2793869B1 (en) 2011-12-21 2015-09-23 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
US9254314B2 (en) * 2013-11-12 2016-02-09 Eric Finzi Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
US20170209553A1 (en) * 2016-01-22 2017-07-27 Transderm, Inc. Delivery of botulinum with microneedle arrays
WO2018023126A1 (en) * 2016-07-29 2018-02-01 Kaspar Roger L Methods of treating osmidrosis
BR112019010131A2 (pt) * 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
CN107320841A (zh) * 2017-08-03 2017-11-07 党明 一种高分子微针及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2022164750A5 (enExample)
JP2019535829A5 (enExample)
Yang et al. Recent advances of microneedles for biomedical applications: drug delivery and beyond
US20220218623A1 (en) Transdermal delivery of large agents
Vaseem et al. Transdermal drug delivery systems: a focused review of the physical methods of permeation enhancement
US7507419B2 (en) Topically applied Clostridium botulinum toxin compositions and treatment methods
JP6046609B2 (ja) 皮膚ケア製品の送達
NZ237197A (en) Ultrasound assisted delivery of drug through intact skin area
JP2014528900A5 (enExample)
JP2014503587A (ja) 界面活性剤組成物
JPWO2020117564A5 (enExample)
AU2025226856A1 (en) Improved Delivery of Large Agents
EP0792164A1 (en) Composition, device, and method for enhanced electrotransport agent delivery
JPWO2018093465A5 (enExample)
JP2025118791A (ja) ピーク効果の遅延および/または応答持続時間の延長
JPWO2020231983A5 (enExample)
DE10103158A1 (de) Vorrichtung zur elektrisch unterstützen Abgabe von Wirkstoffen aus flächenförmigen therapeutischen Systemen
Guy Transdermal science and technology-an update
Ruchitha et al. Ethosomes: nanostructures for enhanced skin penetration
Indermun Pharma-Engineering of a Multifunctional Microneedle Array Device for Application in Chronic Pain
HK40070640A (en) Delaying peak effect and/or extending duration of response
HK40060152A (en) Improved delivery of large agents
Wang et al. Transdermal Drug Delivery Technology
Teslim DEFINITION PHYSIOTHERAPY BY CSP